What Is Optic Neuritis?
Optic neuritis is inflammation of the optic nerve, the cable that carries visual information from the eye to the brain.
It most commonly affects young adults and often presents suddenly. Vision may blur over hours to days. Many patients describe:
- Dimming of vision in one eye
- Pain when moving the eye
- Colours looking washed out
- A central blur or patch
Sometimes the optic disc looks swollen. Sometimes it looks completely normal.
Why Does It Happen?
The most common cause is immune-mediated inflammation.
In many patients, optic neuritis may be associated with neurological conditions such as:
- Multiple Sclerosis
- Neuromyelitis Optica
- Myelin Oligodendrocyte Glycoprotein Antibody Disease
Sometimes it occurs in isolation without any long-term neurological disease.
Infections, autoimmune disorders, and rarely toxins can also cause optic nerve inflammation.
What Does It Feel Like?
Patients often say:
- “My vision feels dimmer, not just blurry.”
- “Colours don’t pop.”
- “It hurts when I look left or right.”
- “One eye just feels off.”
A key clue: colour vision drops disproportionately.
Red especially may appear faded.
What Do We Look For During Examination?
- Reduced visual acuity
- Reduced colour vision
- Relative afferent pupillary defect (RAPD)
- Visual field defect (often central)
- Optic disc swelling (in about one-third of cases)
An MRI of the brain and orbit is usually required, not just to confirm optic nerve inflammation, but to assess neurological risk.
Is It Permanent?
This is the question everyone asks.
The reassuring part:
Most patients recover significant vision over weeks to months.
However:
- Contrast sensitivity may remain reduced
- Some patients notice subtle visual fatigue
- Recurrence can happen
Recovery does not always mean the nerve was untouched. It means the brain compensated well.
Does Everyone With Optic Neuritis Have Multiple Sclerosis?
No.
But optic neuritis can be the first clinical event of MS in some patients.
MRI findings help estimate risk.
If brain MRI shows no demyelinating lesions, long-term MS risk is lower. If lesions are present, risk is higher.
This is why careful evaluation matters: not panic, not dismissal.
When Should You See an Eye Specialist Urgently?
- Sudden visual loss in one eye
- Eye pain with movement
- Colour fading
- Visual dimming over days
These symptoms deserve urgent assessment, ideally within 24–48 hours.
What You Must Remember, Without Fear
I usually explain it like this:
“The optic nerve is inflamed right now. In many cases, vision improves significantly over time. We need to do imaging not because something terrible is happening, but because this helps us understand why the inflammation occurred and whether it connects to anything else in the body.”
Calm clarity works better than alarm.
Common Questions about Optic Neuritis
Will I go blind?
Very unlikely from a single episode. Most recover good functional vision.
Will this happen again?
It depends on the underlying cause. Some never have another episode. Some may, especially in autoimmune conditions.
Do I need steroids?
High-dose steroids may speed recovery. They may not change long-term visual outcome in typical optic neuritis. The decision depends on severity and context.
Important Distinction
Not all optic nerve swelling is optic neuritis.
Papilledema (raised brain pressure)
Ischemic optic neuropathy (blood flow problem)
Infectious optic neuropathy
These require very different management.
Neuro-ophthalmic evaluation is not optional in sudden visual loss.
Role of Steroids in Optic Neuritis
The landmark Optic Neuritis Treatment Trial established that high-dose intravenous methylprednisolone (1 g/day for 3 days followed by oral taper) accelerates visual recovery in typical demyelinating optic neuritis but does not improve long-term visual outcomes compared to placebo. Importantly, oral steroids alone at low dose were associated with a higher recurrence rate and are therefore avoided as monotherapy.
More recent studies have shown that high-dose oral corticosteroids (bioequivalent to IV dosing) may provide similar recovery acceleration when given early, offering a practical alternative in selected patients. However, steroids primarily shorten the duration of visual loss. They usually do not change the final visual acuity in typical MS-associated optic neuritis.
In contrast, in antibody-mediated conditions such as neuromyelitis optica spectrum disorder (NMOSD) or MOG-associated disease, early and aggressive steroid treatment is critical, and delayed escalation (to plasma exchange or immunotherapy) may affect long-term outcomes.
In summary:
Steroids help vision recover faster in typical optic neuritis.
They are essential and time-sensitive in certain immune-mediated forms.
They are not a cure, they are a recovery accelerator.
What About IVIG, Plasma Exchange, or Rituximab?
Most typical optic neuritis (especially when associated with Multiple Sclerosis) improves with time, and high-dose intravenous steroids are often used to accelerate recovery.
However, some optic neuritis cases are not “typical.”
In conditions such as:
- Neuromyelitis Optica
- Myelin Oligodendrocyte Glycoprotein Antibody Disease
The inflammation can be more aggressive and recovery less predictable.
In these situations, additional immune-directed treatments may be required.
1. Plasma Exchange (Plasmapheresis)
Plasma exchange is used in severe cases that do not respond adequately to steroids.
It works by removing circulating antibodies from the bloodstream.
It is usually performed in hospital over several sessions and can significantly improve visual outcomes when used early in steroid-resistant cases.
This is not routine treatment. It is reserved for specific, severe presentations.
2. IVIG (Intravenous Immunoglobulin)
IVIG is sometimes used in:
- Recurrent optic neuritis
- MOG-associated disease
- Certain autoimmune-related optic neuropathies
It helps modulate the immune system rather than suppress it completely.
Its use depends on the underlying diagnosis and neurologist’s recommendation.
3. Rituximab
Rituximab is a monoclonal antibody that reduces B-cell activity.
It is used in:
- Neuromyelitis optica spectrum disorder (NMOSD)
- Recurrent MOG antibody disease
- Certain relapsing autoimmune optic neuropathies
Rituximab is not a treatment for routine, single-episode optic neuritis.
It is considered when there is clear evidence of a relapsing immune condition.
Reassuring Context for Patients of Optic Neuritis
When I discuss these therapies with patients, I frame it like this:
“Most cases improve with standard treatment. These advanced therapies are only needed if we identify a specific immune condition or if recovery is not as expected. The goal is to protect the nerve early and prevent recurrence, and not to escalate treatment unnecessarily.”
The presence of these therapies does not mean the situation is dangerous.
It means we now have options, tailored to the underlying cause.
